PhaseV Raises $15 Million to Push the Boundaries of ML for Clinical Trial Optimization | Healthcare IT Today
Clinical Trial Platform Uncovers Hidden Signals and Optimizes Next Steps for More Adaptive, Successful, and Efficient Clinical Trials
PhaseV, a pioneer in causal machine learning (ML) technology that optimizes clinical trial design and analysis, announced today that it has…
